{
    "contributors": null,
    "coordinates": null,
    "created_at": "Fri Oct 09 14:03:06 +0000 2015",
    "entities": {
        "hashtags": [
            {
                "indices": [
                    17,
                    26
                ],
                "text": "avelumab"
            },
            {
                "indices": [
                    49,
                    60
                ],
                "text": "skincancer"
            },
            {
                "indices": [
                    97,
                    104
                ],
                "text": "pharma"
            }
        ],
        "symbols": [],
        "urls": [
            {
                "display_url": "pharmatimes.com/Article/15-10-\u2026",
                "expanded_url": "http://www.pharmatimes.com/Article/15-10-07/Merck_Pfizer_s_avelumab_fast-tracked_for_rare_skin_cancer.aspx#.VhZ8EOgXAuU.twitter",
                "indices": [
                    61,
                    83
                ],
                "url": "http://t.co/rprRddHL1k"
            }
        ],
        "user_mentions": [
            {
                "id": 35961145,
                "id_str": "35961145",
                "indices": [
                    0,
                    6
                ],
                "name": "Merck",
                "screen_name": "Merck"
            },
            {
                "id": 56488059,
                "id_str": "56488059",
                "indices": [
                    9,
                    16
                ],
                "name": "Pfizer Inc.",
                "screen_name": "pfizer"
            },
            {
                "id": 52354784,
                "id_str": "52354784",
                "indices": [
                    84,
                    96
                ],
                "name": "PharmaTimesMediaLtd",
                "screen_name": "PharmaTimes"
            }
        ]
    },
    "favorite_count": 0,
    "favorited": false,
    "geo": null,
    "id": 652484435342983169,
    "id_str": "652484435342983169",
    "in_reply_to_screen_name": "Merck",
    "in_reply_to_status_id": null,
    "in_reply_to_status_id_str": null,
    "in_reply_to_user_id": 35961145,
    "in_reply_to_user_id_str": "35961145",
    "is_quote_status": false,
    "lang": "en",
    "metadata": {
        "iso_language_code": "en",
        "result_type": "recent"
    },
    "place": null,
    "possibly_sensitive": false,
    "retweet_count": 0,
    "retweeted": false,
    "source": "<a href=\"http://www.hootsuite.com\" rel=\"nofollow\">Hootsuite</a>",
    "text": "@Merck / @Pfizer #avelumab fast-tracked for rare #skincancer http://t.co/rprRddHL1k @PharmaTimes #pharma",
    "truncated": false,
    "user": {
        "contributors_enabled": false,
        "created_at": "Thu Dec 03 16:47:30 +0000 2009",
        "default_profile": false,
        "default_profile_image": false,
        "description": "Plexus Ventures is a leading global business development firm serving the pharmaceutical industry for 25 years.",
        "entities": {
            "description": {
                "urls": []
            },
            "url": {
                "urls": [
                    {
                        "display_url": "plexusventures.com",
                        "expanded_url": "http://www.plexusventures.com",
                        "indices": [
                            0,
                            22
                        ],
                        "url": "http://t.co/aGLtYZaqkH"
                    }
                ]
            }
        },
        "favourites_count": 121,
        "follow_request_sent": false,
        "followers_count": 243,
        "following": false,
        "friends_count": 179,
        "geo_enabled": false,
        "has_extended_profile": false,
        "id": 94365736,
        "id_str": "94365736",
        "is_translation_enabled": false,
        "is_translator": false,
        "lang": "en",
        "listed_count": 49,
        "location": "267-337-7038",
        "name": "Plexus Ventures",
        "notifications": false,
        "profile_background_color": "000000",
        "profile_background_image_url": "http://abs.twimg.com/images/themes/theme15/bg.png",
        "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme15/bg.png",
        "profile_background_tile": false,
        "profile_banner_url": "https://pbs.twimg.com/profile_banners/94365736/1398355842",
        "profile_image_url": "http://pbs.twimg.com/profile_images/556995445/plexus_symbol_normal.JPG",
        "profile_image_url_https": "https://pbs.twimg.com/profile_images/556995445/plexus_symbol_normal.JPG",
        "profile_link_color": "4A913C",
        "profile_sidebar_border_color": "000000",
        "profile_sidebar_fill_color": "000000",
        "profile_text_color": "000000",
        "profile_use_background_image": false,
        "protected": false,
        "screen_name": "PlexusVentures",
        "statuses_count": 3519,
        "time_zone": "Pacific Time (US & Canada)",
        "url": "http://t.co/aGLtYZaqkH",
        "utc_offset": -25200,
        "verified": false
    }
}